(MENAFN- Swissinfo)
Português
(pt)
Nestlé vai vender suas marcas de alimentos para bebês
The deal would "involve the brands sold in France and for export", as well as the Vosges plant at Arches that produces them, according to the press release, which AWP learned about on Friday. It could be finalised during the first half of the year.
"This proposed sale would have no impact on the employees concerned", the multinational assures us. According to French public television, the Vosges site employs 234 people. A CFDT trade union representative interviewed by France 3 Epinal pointed out that "productivity is up. In ten years, we've gone from 16,000 tonnes to 33,000.
But he acknowledged that the fall in the number of births in France was affecting the business: "We're getting a smaller slice of the cake, and that's having an impact on us", he said.
+ Three Swiss companies among the 100 most valuable in the world
Until the transaction is complete, the teams responsible for these activities in Issy-les-Moulineaux, where Nestlé France is headquartered, and in Arches will continue their activities within the group.
Focus on infant formulas
Nestlé France will withdraw from the NaturNes, Babicao and Babivanille baby food brands, as well as the P'tit franchises, in order to "strengthen the development of its infant formula business, a historical and strategic pillar of the group", according to the document. Nidal and Guigoz infant and growing-up milks are manufactured in Boué in northern France.
+ How Nestle Factories Keep Running in a Country Torn by Putin's War
In 2022, Nestlé sold its Mousline mashed potato brand to the French investment fund FnB, with which the group had entered into exclusive negotiations. This Paris-based fund specialises in supporting SMEs that process and market food products. In November, the French subsidiary of the Romande-based multinational also began talks with Italy's Italpizza to sell its Caudry plant in the north of the country, following the scandal involving Buitoni pizzas contaminated by E.Coli bacteria.
Translated from French by DeepL/amva
Send us your input
Do you have more questions about this story?
Your contribution Our journalists will take your contribution on board for their coverage and may follow up with you via email. If you have questions, get in touch . Your contribution... How we work
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them hereExternal link .
If you want to know more about how we work, have a look hereExternal link , and if you have feedback on this news story please write to ...External link .
End of insertion External Content Your subscription could not be saved. Please try again. Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you. Daily news
Get the most important news from Switzerland in your inbox.
Daily
Email
The SBC Privacy Policy provides additional information on how your data is processed.
I consent to the use of my data for the SWI swissinfo newsletter.
Articles in this story
Do you have more questions about this story?
In compliance with the JTI standards
More: SWI swissinfo certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at ... .
MENAFN02022024000210011054ID1107803209
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.